Literature DB >> 24169086

Genomic aberrations in anaplastic multiple myeloma: high frequency of 1q21(CKS1B) amplifications.

Mohammad Bahmanyar1, Xiaoying Qi, Hong Chang.   

Abstract

Anaplastic multiple myeloma (AMM) is a rare morphologic variant of MM with adverse prognosis. The underlying molecular cytogenetic abnormalities are poorly understood. We investigated 11 patients with AMM for myeloma associated cytogenetic aberrations and compared with 188 non-anaplastic MM using fluorescent in situ hybridization. Of the 11 AMM patients studied, 10 had CKS1B amplification, 5 hemizygous 17p(p53) deletions, 4 13q14 deletions, 4 t(4:14), and 2 had t(11:14). AMM was associated with significantly higher prevalence of CKS1B amplification (91% vs. 34%, p<0.001), 17p(p53) deletion (45% vs. 11%, p=0.006) and t(4,14) (36% vs. 14%, p=0.015) than non-anaplastic MM, which may have resulted in the genetic instability and more aggressive clinical course.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anaplastic myeloma; CKS1B; FISH; Multiple myeloma; Prognosis

Mesh:

Substances:

Year:  2013        PMID: 24169086     DOI: 10.1016/j.leukres.2013.09.025

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  9 in total

Review 1.  Plasma cell myeloma: role of histopathology, immunophenotyping, and genetic testing.

Authors:  Megan J Fitzpatrick; Valentina Nardi; Aliyah R Sohani
Journal:  Skeletal Radiol       Date:  2021-03-09       Impact factor: 2.199

2.  Successful outcome of anaplastic multiple myeloma with lenalidomide, cyclophosphamide, and dexamethasone therapy.

Authors:  Wenjiao Tang; Yangfan Xu; Bing Xiang
Journal:  Ann Hematol       Date:  2020-09-02       Impact factor: 3.673

3.  Identification and pharmacological inactivation of the MYCN gene network as a therapeutic strategy for neuroblastic tumor cells.

Authors:  Olesya Chayka; Cosimo Walter D'Acunto; Odette Middleton; Maryam Arab; Arturo Sala
Journal:  J Biol Chem       Date:  2014-12-04       Impact factor: 5.157

4.  Morphological Transformation of Myeloma Cells into Multilobated Plasma Cell Nuclei within 7 Days in a Case of Secondary Plasma Cell Leukemia That Finally Transformed as Anaplastic Myeloma.

Authors:  Akihito Fujimi; Yasuhiro Nagamachi; Naofumi Yamauchi; Yuji Kanisawa
Journal:  Case Rep Hematol       Date:  2017-12-21

5.  Pleomorphic Multinucleated Plasma Cells Simulating Megakaryocytes in an Anaplastic Variant of Myeloma.

Authors:  Shivangi Harankhedkar; Ruchi Gupta; Khaliqur Rahman
Journal:  Turk J Haematol       Date:  2018-02-06       Impact factor: 1.831

6.  Anaplastic multiple myeloma with MYC rearrangement.

Authors:  Satoshi Ichikawa; Noriko Fukuhara; Ko Hashimoto; Fumiyoshi Fujishima; Ryo Ichinohasama; Hideo Harigae
Journal:  Leuk Res Rep       Date:  2021-12-27

7.  Anaplastic Multiple Myeloma: Case Series and Literature Review.

Authors:  Jian Wu; Emily Chu; Cristiana Costa Chase; Taewoong Choi; Cristina Gasparetto; Ken Young; Yubin Kang
Journal:  Asploro J Biomed Clin Case Rep       Date:  2022-01-15

8.  CKS protein overexpression renders tumors susceptible to a chemotherapeutic strategy that protects normal tissues.

Authors:  John Tat; Céline Loriot; Martha Henze; Charles Spruck; Brunhilde H Felding; Steven I Reed
Journal:  Oncotarget       Date:  2017-12-04

9.  Poor response to daratumumab and carfilzomib in newly diagnosed anaplastic multiple myeloma.

Authors:  Masuho Saburi; Masao Ogata; Yasuhiro Soga; Yoshiyuki Kondo; Ryo Kurimoto; Kazuhito Itani; Kazuhiro Kohno; Hiroki Uchida; Toshiyuki Nakayama
Journal:  J Clin Exp Hematop       Date:  2020
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.